Alfa Cytology employs the latest research technology.
Scientific Excellence
Customized Solutions
Collaborative Approach
Confidentiality and Data Security
Explore our solutions to gain a deeper understanding of specific diseases and drive advancements in cancer resarch.
Learn about our research services dedicated to understanding and treating eye cancers, with a focus...
Discover our comprehensive range of services for gynecologic cancer research, offering advanced...
Learn about our cutting-edge solutions for studying and combating head and neck cancers, providing...
Explore our research services focused on understanding and addressing lung cancers...
Discover our expertise in skin cancer research, offering advanced diagnostic tools, molecular...
Learn how our comprehensive range of services can support bladder cancer research, providing valuable...
Discover our specialized services tailored to studying cancers of the lymphatic system and blood...
Learn about our cutting-edge solutions for studying and combating bone and soft tissue cancers...
Explore our services focused on understanding and addressing brain and nervous system cancers...
Learn how our comprehensive range of services can support breast cancer research, from biomarker discovery...
Discover our expertise in gastrointestinal cancer research, providing valuable insights into...
Explore our specialized services for studying thyroid cancer, including hormone-based therapies...
From immune checkpoint inhibitors to growth inhibitors and metabolic modulators, we are dedicated to advancing the field of cancer therapy.
We specialize in developing therapies that target immune checkpoints, such as PD-1, PD-L1, and CTLA-4, to enhance the body's immune response to cancer cells.
Our services focus on the development of growth inhibitors to disrupt cancer cell growth pathways, e.g., CDK, VEGF-VEGFR, PI3K/AKT/mTOR pathway, PARP, and disrupt tumor cell survival.
Our company is dedicated to the development of cytokine and chemokine pathway inhibitors that inhibit angiogenesis and interfere with tumor cell metabolism, e.g., inhibition of TNF-α, IL-1, IL-6, chemokine receptors, etc.
We offer expertise in developing inhibitors that target specific protein kinases implicated in cancer, e.g., EGFR, HER2, ALK .
Our company focuses on the development of tumor stem cell inhibitors, with a particular focus on key signaling pathway inhibitors such as Notch and Wnt.
Our company is deeply engaged in the research field of TAM modulator, especially in the three key targets of AXL, MER and TYRO3.
In our company's scientific research, the study of NK modulators has been at the core of our research, especially on a series of key targets such as NKG2D, NKp30, NKp44, NKp46, NKG2A, and KIR.
IAP Inhibitors research has always been at the core of our company's research, and we have focused on the in-depth study of key targets such as XIAP, cIAP1, and the NF-κB pathway.
In the field of autophagy modulator research, our company has a deep professional background and unique technical advantages, with a special focus on key targets such as VPS34, ATG, mTOR and Beclin 1.
From small molecule drugs and therapeutic antibodies to cell-based therapies and gene therapies, we offer comprehensive support for the development of innovative treatments.
Our services encompass target identification, lead optimization, medicinal chemistry, and preclinical evaluation of small molecule drugs.
Our services include antibody discovery, engineering, optimization, and production, with the aim of developing targeted and immunotherapeutic approaches to cancer treatment.
Our expertise lies in the development and optimization of cell therapies, contributing to the advancement of personalized and immunotherapeutic strategies against cancer.
Our services cover gene delivery systems, gene editing technologies, and the development of viral vectors to enable precise and targeted interventions in cancer cells.
Our services encompass antigen selection, vaccine design, and immunogenicity evaluation, contributing to the development of preventive and therapeutic cancer vaccines.
Our expertise includes peptide design, synthesis, modification, and pharmacological evaluation, enabling the development of tailored and targeted peptide therapeutics.
We offer a range of specialized services tailored to each phase, enabling comprehensive exploration and advancement in the field of oncology.
